Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in‐hospital and long‐term outcomes – from the ESC‐HFA EORP Heart Failure Long‐Term Registry

Author:

Kapłon‐Cieślicka Agnieszka1,Benson Lina2,Chioncel Ovidiu3,Crespo‐Leiro Maria G.4,Coats Andrew J.S.5,Anker Stefan D.6,Ruschitzka Frank7,Hage Camilla28,Drożdż Jarosław9,Seferovic Petar10,Rosano Giuseppe M.C.11,Piepoli Massimo12,Mebazaa Alexandre13,McDonagh Theresa14,Lainscak Mitja15,Savarese Gianluigi28,Ferrari Roberto16,Mullens Wilfried17,Bayes‐Genis Antoni18,Maggioni Aldo P.19,Lund Lars H.28ORCID,

Affiliation:

1. 1st Chair and Department of Cardiology Medical University of Warsaw Warsaw Poland

2. Department of Medicine Solna Karolinska Institutet Stockholm Sweden

3. Emergency Institute for Cardiovascular Diseases ‘Prof. C.C. Iliescu’ and University of Medicine Carol Davila Bucharest Romania

4. Unidad de Insuficiencia Cardiaca y Trasplante Cardiaco, Complexo Hospitalario Universitario A Coruna (CHUAC), INIBIC, Universidad de A Coruña (UDC), CIBERCV La Coruna Spain

5. Heart Research Institute Sydney Australia

6. Department of Cardiology (CVK) Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin Berlin Berlin Germany

7. Department of Cardiology University Hospital Zurich, University of Zurich Zurich Switzerland

8. Department of Cardiology Heart, Vascular and Neuro Theme, Karolinska University Hospital Stockholm Sweden

9. Department of Cardiology Medical University of Lodz Lodz Poland

10. Faculty of Medicine, University of Belgrade, and Serbian Academy of Sciences and Arts Belgrade Serbia

11. St George's Hospitals NHS Trust University of London, UK, and University San Raffaele and IRCCS San Raffaele Rome Italy

12. Clinical Cardiology, IRCCS Policlinico San Donato Milanese Milan Italy

13. Université de Paris, MASCOT, Inserm, and Department of Anesthesia, Burn and Critical Care Medicine, AP‐HP, Hôpital Lariboisière Paris France

14. King's College Hospital London UK

15. Division of Cardiology, General Hospital Murska Sobota, Murska Sobota, and Faculty of Medicine, University of Ljubljana Ljubljana Slovenia

16. Centro Cardiologico Universitario di Ferrara, University of Ferrara, and Maria Cecilia Hospital, GVM Care & Research Cotignola Italy

17. Ziekenhuis Oost‐Limburg, Genk and Hasselt University Hasselt Belgium

18. CIBER Cardiovascular, Madrid, Institut del Cor, Hospital Universitari Germans Trias i Pujol, Barcelona, Department of Medicine, Universitat Autònoma de Barcelona Barcelona Spain

19. ANMCO Research Center, Heart Care Foundation Florence Italy

Abstract

AbstractAimsTo comprehensively assess hyponatraemia in acute heart failure (AHF) regarding prevalence, associations, hospital course, and post‐discharge outcomes.Methods and resultsOf 8298 patients in the European Society of Cardiology Heart Failure Long‐Term Registry hospitalized for AHF with any ejection fraction, 20% presented with hyponatraemia (serum sodium <135 mmol/L). Independent predictors included lower systolic blood pressure, estimated glomerular filtration rate (eGFR) and haemoglobin, along with diabetes, hepatic disease, use of thiazide diuretics, mineralocorticoid receptor antagonists, digoxin, higher doses of loop diuretics, and non‐use of angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers and beta‐blockers. In‐hospital death occurred in 3.3%. The prevalence of hyponatraemia and in‐hospital mortality with different combinations were: 9% hyponatraemia both at admission and discharge (hyponatraemia Yes/Yes, in‐hospital mortality 6.9%), 11% Yes/No (in‐hospital mortality 4.9%), 8% No/Yes (in‐hospital mortality 4.7%), and 72% No/No (in‐hospital mortality 2.4%). Correction of hyponatraemia was associated with improvement in eGFR. In‐hospital development of hyponatraemia was associated with greater diuretic use and worsening eGFR but also more effective decongestion. Among hospital survivors, 12‐month mortality was 19% and adjusted hazard ratios (95% confidence intervals) were for hyponatraemia Yes/Yes 1.60 (1.35–1.89), Yes/No 1.35 (1.14–1.59), and No/Yes 1.18 (0.96–1.45). For death or heart failure hospitalization they were 1.38 (1.21–1.58), 1.17 (1.02–1.33), and 1.09 (0.93–1.27), respectively.ConclusionAmong patients with AHF, 20% had hyponatraemia at admission, which was associated with more advanced heart failure and normalized in half of patients during hospitalization. Admission hyponatraemia (possibly dilutional), especially if it did not resolve, was associated with worse in‐hospital and post‐discharge outcomes. Hyponatraemia developing during hospitalization (possibly depletional) was associated with lower risk.

Funder

AstraZeneca

Bayer

Boehringer Ingelheim

Boston Scientific Corporation

Daiichi Sankyo Europe

Edwards Lifesciences

ResMed

Sanofi

Servier

Vifor Pharma

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3